Femasys (FEMY) EBITDA Margin (QoQ) (2020 - 2025)
Powered by 
Analysis
Femasys (FEMY) EBITDA Margin (QoQ) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn |
| 10 | Femasys | 9.38 Mn | 7.94 Mn | 189,391.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 65,903.00 |
| Mar 31, 2025 | -78,808.00 |
| Dec 31, 2024 | 11,036.00 |
| Sep 30, 2024 | 110,130.00 |
| Jun 30, 2024 | -74,662.00 |
| Mar 31, 2024 | 81,082.00 |
| Dec 31, 2023 | -41,771.00 |
| Sep 30, 2023 | -75,416.00 |
| Jun 30, 2023 | 11,862.00 |
| Mar 31, 2023 | 24,623.00 |
| Dec 31, 2022 | -40,099.00 |
| Sep 30, 2022 | -233.00 |
| Jun 30, 2022 | 1,937.00 |
| Mar 31, 2022 | 3,013.00 |
| Dec 31, 2021 | -9,188.00 |
| Sep 30, 2021 | -25,202.00 |
| Jun 30, 2021 | -2,926.00 |
| Mar 31, 2021 | 3,854.00 |
| Dec 31, 2020 | -9,278.00 |
| Sep 30, 2020 | 31,006.00 |